Home » Trials » SLCTR/2014/022


Randomised controlled trial to assess the retention of immediate post-delivery insertion of an intrauterine contraceptive device versus interval intrauterine contraceptive device insertion

-

SLCTR Registration Number

SLCTR/2014/022


Date of Registration

02 Oct 2014

The date of last modification

Mar 03, 2019



Application Summary


Scientific Title of Trial

Randomised controlled trial to assess the retention of immediate post-delivery insertion of an intrauterine contraceptive device versus interval intrauterine contraceptive device insertion


Public Title of Trial

Success of intrauterine contraceptive device retention just after the delivery


Disease or Health Condition(s) Studied

Contraception


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

U1111-1155-3985


Any other number(s) assigned to the trial and issuing authority

P/162/08/2014 (Ethics Review Committee, Faculty of Medicine, University of Kelaniya)


Trial Details


What is the research question being addressed?

What is the rate of successful retention of the copper intrauterine device (IUD) when inserted within 10 minutes of placental delivery, compared to insertion at 6–8 weeks postpartum?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Active


Assignment

Parallel


Purpose

Prevention


Study Phase

Not Applicable


Intervention(s) planned

Participants will be randomized at admission to receive either immediate post-placental or interval IUD insertion. The participants will be offered an ultrasound scan and 12 hours and at 6-8 weeks postpartum.

Expelled IUDs will be replaced according to patient preference.


Inclusion criteria

  1. Women with planned vaginal deliveries
  2. Desire for copper IUD insertion

Exclusion criteria

  1. Any contraindications for IUD insertion including infection, hemorrhage and caesarian delivery


Primary outcome(s)

1.

Retention of IUD within uterine cavity

[

At 12 hours of insertion and at 6-8 weeks post partum

]

Secondary outcome(s)

1.

None

[

None

]

Target number/sample size

86


Countries of recruitment

Sri Lanka


Anticipated start date

2014-11-01


Anticipated end date

2014-05-31


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source

None


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2014-08-06


Approval number

P/162/08/2014


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Kelaniya
Institutional Address:PO Box 6, Thalagolla Road, Ragama Sri Lanka
Telephone:+94-11-2961267
Email: erckelaniya@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr Tiran Dias
Consultant Obstetrician and Gynaecologist
Senior Lecturer, Department of Obstetrics and Gynaecology, Faculty of Medicine University of Kelaniya Sri Lanka

0094773051142

thiran_dias@yahoo.com

Contact Person for Public Queries

Dr Tiran Dias
Consultant Obstetrician and Gynaecologist
Senior Lecturer, Department of Obstetrics and Gynaecology, Faculty of Medicine University of Kelaniya Sri Lanka

0094773051142

thiran_dias@yahoo.com


Primary study sponsor/organization

District General Hospital, Ampara

Postal Code 32000, Ampara, Sri Lanka
+94632222261
+94632222261
ghampara@gmail.com
http://www.ghampara.gov.lk/

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results